Christopher Lobo

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 854 citations

End-of-study Results, Breast Oncology, Medicine +8

Digital Clubbing and Lung Cancer

Kasi S. Sridhar, Christopher Lobo, Roy D. Altman · CHEST Journal · 1998 · 109 citations · Full text

Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

Christopher Lobo, Gilberto Lopes, Odalys Baez et al. · Breast Cancer Research and Treatment · 2010 · 89 citations

First-line Therapy, Breast Oncology, Oncology +7

An algorithm for early diagnosis of cervicofacial necrotising fasciitis

Vikas Malik, Chaitanya Gadepalli, Shailesh Agrawal et al. · European Archives of Oto-Rhino-Laryngology · 2010 · 46 citations

Early Diagnosis, Medical Imaging, Medicine +8

Paclitaxel albumin-bound particles (abraxane™) in combination with bevacizumab with or without gemcitabine: Early experience at the University of Miami/Braman Family Breast Cancer Institute

Christopher Lobo, Gilberto Lopes, Orlando Silva et al. · Biomedicine & Pharmacotherapy · 2007 · 23 citations

Paclitaxel Albumin-bound Particles, Breast Oncology, Oncology +7